Cédric Jehanno

Cédric is currently the Director of Health Economics and Outcomes Research at Merck, where he leads the development and implementation of strategies to demonstrate pharmaceutical value in support of market access and reimbursement. With over 15 years of experience in the Health Technology Assessment (HTA) and market access environment, Cédric possesses a deep understanding of the Canadian pharmaceutical landscape, its key stakeholders, and their strategic priorities. 

Prior to Merck, Cédric spent over a decade at INESSS, culminating as Scientific Coordinator in Health Economics, where he led economic evaluations. Since joining Merck, he has spearheaded the development and execution of local value evidence generation strategies, leveraging Real World Evidence (RWE) and his HTA expertise in support of policy, patient access, and complex strategic submissions. Demonstrating his commitment to system-level collaboration, Cédric also serves as an industry representative in quarterly liaison meetings with INESSS to foster constructive dialogue and improve access pathways. 

Cédric holds a Master’s degree in Pharmaceutical Science with a specialization in Pharmacoeconomy from Université de Montréal and a MBA in Pharmaceutical Management from Université Laval.